linkedin post 2013-01-26 04:27:49

Uncategorized
CUMULATIVE PATENT VALUES IN THE US ARE VAST, equal to almost half the value of the GDP. This unusual article does a great job of surveying the landscape of players from IP brokers to litigators. Be aware that today, most IP of value will be challenged in court for obviousness or prior art. An important strategy is to send a patent draft to s good patent litigator in your field and asses the weaknesses in the application. This allows you to stress test the IP before you file it. IP is your most valuable asset. Invest in developing a thorough IP strategy going forward. http://lnkd.in/KZ6F9i View in LinkedIn
Read More

linkedin post 2013-01-25 07:06:49

Uncategorized
DIAGNOSIS, EVEN WITHOUT TREATMENT IS VITAL FOR FAMILIES. Diseases like Batten Disease and Duchenne MuscularDystrophy wreck families. Even when there is no cure, families have consistent chosen definitive testing to solve the diagnosis, so they can end the doubts, end the endless years of clinical assessments, and plan for the remaining years. http://lnkd.in/q5xQ7H View in LinkedIn
Read More

linkedin post 2013-01-25 06:58:38

Uncategorized
WILL WE DEVELOP A TWO TIERED HEALTHCARE WORLD? Inevitable downward price pressures from the developing world will obviously favor generic drugs, while the quest for better medicines will drive developed world innovation. How this plays out globally is a key issue for public health. http://social.eyeforpharma.com/market-access/patent-war-mncs-change-their-battle-strategy-india View in LinkedIn
Read More

linkedin post 2013-01-26 07:47:45

Uncategorized
SBIR GRANTS have always been an important factor in financing many early stage biopharma companies. While increasingly competitive in recent years, this non-dilutive funding is often a green light to investors that the emerging company has competitive science and a drive to compete for future funding. http://lnkd.in/gE-zP6 View in LinkedIn
Read More

linkedin post 2013-01-25 06:53:18

Uncategorized
GREAT ADVICE EVERY ENTREPRENEUR MUST INTERNALIZE. These are the KEY questions to ask of a VC, period. You MUST get answers before you say yes to an investment. A wrong VC can wreck your company as quickly as no VC can. And remember, when you go for Series B, the VC investors you have selected will come under as much scrutiny as your company, and they can be a very fastidious bunch. http://lnkd.in/NfntTa View in LinkedIn
Read More